Junqiang Tian

4PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 11, 2026
The pre-treatment tumor microenvironment immune status determines Bacillus Calmette-Guerin immunotherapy response in early-stage bladder cancer.

|Jan 18, 2026
TAK-901 Targeted Inhibition of EGFR Activates Transcription Factor FOXO, Causing Cell-cycle Arrest and Apoptosis in Bladder Cancer.

Lanpeng Lu, Hui Cheng, Shanhui Liu

|Jan 29, 2022
The analysis of N6-methyladenosine regulators impacting the immune infiltration in clear cell renal cell carcinoma.

Jianpeng Li, Jinlong Cao, Cheng Liang

|Jun 24, 2021
Integrative analysis of immune molecular subtypes and microenvironment characteristics of bladder cancer.

Jinlong Cao, Jianpeng Li, Xin Yang

Pageof 1

Frequent Collaborators

2 joint publications

Zhiping Wang

1 joint publications

Jinlong Cao

1 joint publications

Jianpeng Li

1 joint publications

Zhiqiang Yao